This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Last revision Both sides next revision | ||
documentation:vocabulary:bdpm [2016/07/20 12:04] dimshitc1 |
documentation:vocabulary:bdpm [2016/07/21 13:26] dimshitc1 |
||
---|---|---|---|
Line 1: | Line 1: | ||
- | All the drug concepts have only relationship_id = 'Maps to' relates to RxNorm Extended or RxNorm concepts | + | Overall Structure of vocabulary is meets criteria described here:\\ http://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:drug |
- | RxNorm and RxNorm extended concept then have all usual relationships and drug_strenght tables (between Ingredient and Drug, Brand Name and Branded Drug and other) | + | All the drug concepts have only relationship_id = 'Maps to' relates to RxNorm Extended or RxNorm concepts. |
- | bla-bla | + | RxNorm and RxNorm extended concepts have all usual relationships (between Ingredient and Drug, Brand Name and Branded Drug and other) and drug_strenght information. |
- | 1.standard / non-standard ingredients | + | |
+ | |||
+ | 1. CIS_COMPO_bdpm table (containing drug and Ingredient dosages) contains both precise ingredient dosage (acting ingredient and base or salt it exists wiht) and dosage of active ingredient if such ambigousness is possible. We put in OMOP tables only active substance dosage. | ||
2.Brand Names rules | 2.Brand Names rules |